Pluripotent stem cells in disease modelling and drug discovery.
about
Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative DiseasesInherited heart disease - what can we expect from the second decade of human iPS cell research?iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.A case report of novel mutation in PRF1 gene, which causes familial autosomal recessive hemophagocytic lymphohistiocytosis.Generation of induced Pluripotent Stem Cells as disease modelling of NLSDMInduced Pluripotent Stem Cells Meet Genome EditingPluripotent stem cells: the last 10 years.Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease.Humanized neuronal chimeric mouse brain generated by neonatally engrafted human iPSC-derived primitive neural progenitor cells.Parent-of-Origin DNA Methylation Dynamics during Mouse Development.Optimized inducible shRNA and CRISPR/Cas9 platforms for in vitro studies of human development using hPSCs.Adipose-Derived Mesenchymal Stem Cells for Treatment of Airway Injuries in A Patient after Long-Term Exposure to Sulfur Mustard.Molecular dissection of germline chromothripsis in a developmental context using patient-derived iPS cells.Generation of a bile salt export pump deficiency model using patient-specific induced pluripotent stem cell-derived hepatocyte-like cellsMultiple Roles of MYC in Integrating Regulatory Networks of Pluripotent Stem Cells.Cell population structure prior to bifurcation predicts efficiency of directed differentiation in human induced pluripotent cellsGeneration of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method.Neuroregeneration versus neurodegeneration: toward a paradigm shift in Alzheimer's disease drug discovery.A comparative review of computational methods for pathway perturbation analysis: dynamical and topological perspectives.Nicotinamide alone accelerates the conversion of mouse embryonic stem cells into mature neuronal populations.High-Throughput and Cost-Effective Characterization of Induced Pluripotent Stem Cells.Editing the genome of hiPSC with CRISPR/Cas9: disease models.An update on stem cell biology and engineering for brain development.Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.Delayed Mesoderm and Erythroid Differentiation of Murine Embryonic Stem Cells in the Absence of the Transcriptional Regulator FUBP1.Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes (hPSC-CMs) Using Multi-electrode Arrays (MEAs)A new era of disease modeling and drug discovery using induced pluripotent stem cells.Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?Early Perspective.Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia.Genetic ablation of the mammalian sterile-20 like kinase 1 (Mst1) improves cell reprogramming efficiency and increases induced pluripotent stem cell proliferation and survival.Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.Cell fate conversion-from the viewpoint of small molecules and lineage specifiers.Impact of lysosomal storage disorders on biology of mesenchymal stem cells: Evidences from in vitro silencing of glucocerebrosidase (GBA) and alpha-galactosidase A (GLA) enzymes.Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome.Induced pluripotent stem cell technology: a decade of progress.Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.Bringing new dimensions to drug discovery screening: impact of cellular stimulation technologies.Pluripotent stem cells in neuropsychiatric disorders.Apolipoprotein E, Receptors, and Modulation of Alzheimer's Disease.
P2860
Q28067160-B7A05980-15F6-4420-B8E7-36BA1E176389Q28079217-985609CF-4165-4CA5-B62D-B1C5443A1C1EQ33559864-97FDF3FC-46C0-4EF7-A81A-25690584813DQ33634875-F659504F-A7E6-48A6-9C59-1F9A5E23C7DEQ33695645-6256266F-9D8E-44DE-85A0-DAB45EDD58B7Q34525438-3380BCDD-38B6-4501-8CAF-A1BDE76FCE63Q34546417-140C2DD0-2C50-4B23-8AA5-498DC7B1C33EQ34557892-8DE2C93A-0AAF-4DA3-91C9-C6C813654DBCQ37417503-B9BD7351-4943-4177-AD32-CC195295AF94Q37429075-89DDA491-27E7-42CE-A74B-BAB317DE718CQ37545744-75A51CE4-ADCF-46C8-A869-1A658FCADAFFQ37590912-59495846-BE23-4356-8CB1-00707B1B21A6Q37609839-BBB447FA-481D-4011-A5ED-8A8973BA4F0EQ37620655-5DFAA0D6-DF90-476A-84BF-E50DB0B93BC0Q37622098-23DA5C34-AD8E-40EC-BD90-98F72F19A0DFQ37682369-E267121E-014C-47BD-98F9-929BFCA15277Q37740413-A8499D90-7FDC-4CC0-9E9B-72CCDA6A3A15Q38668995-2DAFFBBD-2603-4DC3-8E22-DE590874DC6FQ38676091-13CE1F2C-3EE2-4B06-9053-40EC557AE2EEQ38694699-E6894454-EA22-4046-84A8-B5F7F9764233Q38707631-E2CC4546-8E30-43FD-9A8F-ECE1E0DE66DCQ38711908-6CEF35B8-A667-4E0F-92DB-47CD779E5733Q38735486-192A07FD-5254-4361-9C2E-A2904FE9DAE4Q38738107-FFE2EB4D-4708-40A6-BFC3-1172B09AD837Q38739565-D5027570-ADD5-45D6-AA6F-37FB467A35A3Q38750884-49C49E6F-4E67-49D6-8137-5AD0CC32F0C6Q38786732-CC631CF4-39DF-4C8B-9A09-AFA8BF133CEDQ38819976-D52929B5-BCD1-47D6-B30B-B1086B5211EFQ38843033-B0F8B474-7783-4DAA-947D-21B3D92E8422Q38903697-7CB107D4-DE9C-47EE-A209-A27F5E8CF82CQ38930653-3885F061-34E3-4184-838C-3024A6E7C6CDQ38945910-FC74FF25-5077-4A55-9189-52CA5ACE80BAQ38951137-0B53B7A7-9814-482B-B6E6-DF3AC42623B9Q39015281-685E20BC-D84D-4EF5-945A-3FB5459EFAB2Q39024323-CC84B4FD-C992-4D24-B9EB-21F773162900Q39040578-E579D705-DDE0-4586-A723-A6B022F38BD5Q39063423-C5564D79-6348-46C1-8C4A-C745C73AF0C2Q39126913-AE64D6C3-485D-488A-98E2-446D8B120D38Q39189500-57803E0B-7EA7-4669-9E3F-564A50B5B66AQ39257249-2056BC36-C588-4474-B6BB-82D50C2A23CF
P2860
Pluripotent stem cells in disease modelling and drug discovery.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pluripotent stem cells in disease modelling and drug discovery.
@en
type
label
Pluripotent stem cells in disease modelling and drug discovery.
@en
prefLabel
Pluripotent stem cells in disease modelling and drug discovery.
@en
P2860
P356
P1476
Pluripotent stem cells in disease modelling and drug discovery.
@en
P2093
Yishai Avior
P2860
P2888
P304
P356
10.1038/NRM.2015.27
P577
2016-01-28T00:00:00Z
P6179
1010993477